Financhill
Sell
20

ZNTL Quote, Financials, Valuation and Earnings

Last price:
$1.36
Seasonality move :
-21.46%
Day range:
$1.32 - $1.38
52-week range:
$1.01 - $3.33
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.63x
P/B ratio:
0.39x
Volume:
556.5K
Avg. volume:
685.7K
1-year change:
-57.37%
Market cap:
$98.3M
Revenue:
$67.4M
EPS (TTM):
-$2.08

Earnings Data

Next earnings date for ZNTL
Mar 26
2026
Most recent earnings per share
-$0.37
Beat by $0.11
(Nov 10/2025)
Consensus Estimate
-$0.48
(Nov 10/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ZNTL Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/26/2026 Q4 -- -- -- -$0.40 --
11/10/2025 Q3 -- -- -$0.37 -$0.48 $0.11
08/08/2025 Q2 -- -- -$0.37 -$0.52 $0.15
05/07/2025 Q1 -- -- -$0.67 -$0.61 -$0.07
03/26/2025 Q4 -- $26.9M -$0.67 -$0.68 $0.02
11/12/2024 Q3 -- -- -$0.56 -$0.87 $0.31
08/09/2024 Q2 -- -- -$1.24 -$0.83 -$0.42
05/07/2024 Q1 $11.7M $40.6M $0.14 -$0.74 $0.88
02/27/2024 Q4 -- -- -$0.86 -$0.84 -$0.02
11/06/2023 Q3 -- -- -$0.79 -$0.94 $0.15
08/09/2023 Q2 -- -- -$1.85 -- --
05/10/2023 Q1 -- -- -$1.07 -- --
02/24/2023 Q4 -- -- -$0.93 -- --
11/09/2022 Q3 -- -- -$0.96 -- --
08/09/2022 Q2 -- -- -$1.34 -- --
05/05/2022 Q1 -- -- -$1.31 -- --
02/24/2022 Q4 -- -- -$1.11 -- --
11/10/2021 Q3 -- -- -$0.09 -- --
08/12/2021 Q2 -- -- -$1.34 -- --
05/17/2021 Q1 -- -- -$1.24 -- --
03/25/2021 Q4 -- -- -$0.98 -- --
11/09/2020 Q3 -- -- -$0.91 -- --
08/13/2020 Q2 -- -- -$0.78 -- --
05/15/2020 Q1 -- -- -$0.45 -- --
12/31/2019 Q4 -- -- -$0.40 -- --
09/30/2019 Q3 -- -- -$2.20 -- --
06/30/2019 Q2 -- -- -$0.29 -- --
03/31/2019 Q1 -- -- -$0.23 -- --

Zentalis Pharmaceuticals, Inc. Earnings Questions

  • How Much did Zentalis Pharmaceuticals, Inc. Generate in Revenue Last Quarter?

    Zentalis Pharmaceuticals, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Zentalis Pharmaceuticals, Inc. Beat Earnings Last Quarter?

    Zentalis Pharmaceuticals, Inc. announced earnings per share of -$0.37 which represents a beat of analyst forecast a -$0.48 per share.

  • Is Zentalis Pharmaceuticals, Inc. Profitable?

    Zentalis Pharmaceuticals, Inc. reported -$160K that represents -$0.00 per share over the last quarter.

  • What is the Analyst Consensus for Zentalis Pharmaceuticals, Inc. EPS Next Year?

    Zentalis Pharmaceuticals, Inc.'s earnings are forecast to decrease from -$2.33 per share to -$2.40 per share next year representing a decrease of -24.5%.

  • When is Zentalis Pharmaceuticals, Inc.'s Earnings Date?

    Zentalis Pharmaceuticals, Inc.'s next earnings date is March 26, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 65x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
72
GLTO alert for Dec 27

Galecto, Inc. [GLTO] is up 16.92% over the past day.

Sell
20
SMX alert for Dec 27

SMX (Security Matters) Plc [SMX] is down 15.76% over the past day.

Sell
11
CDNAF alert for Dec 27

Canadian Tire Corp. Ltd. [CDNAF] is down 10% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock